Carmel, IN, United States of America

Cen Gao

This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignee: Moma Therapeutics. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Cen Gao. Retrieved from https://idiyas.com/inventor/cen-gao-npcy480z

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 50.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Cen Gao: Innovator in Pharmaceutical Chemistry

Introduction

Cen Gao is a prominent inventor based in Carmel, IN (US). She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that modulate DNA polymerase Θ activity. Her work holds promise for the treatment of various disorders, including cancer.

Latest Patents

Cen Gao holds a patent for "Semi-saturated bicyclic derivatives and related uses." This patent relates to compounds of Formula (I) and their prodrugs, pharmaceutically acceptable salts, pharmaceutical compositions, methods of use, and methods for their preparation. The compounds disclosed are particularly useful for modulating DNA polymerase Θ activity, which is implicated in several disorders.

Career Highlights

Cen Gao is currently associated with Moma Therapeutics, where she continues to advance her research and development efforts. Her innovative work has led to the creation of valuable pharmaceutical compounds that may significantly impact cancer treatment.

Collaborations

Cen has collaborated with notable colleagues, including Michael H Reutershan and Timothy J Guzi. These partnerships have enhanced her research capabilities and contributed to the success of her projects.

Conclusion

Cen Gao is a dedicated inventor whose work in pharmaceutical chemistry is paving the way for new treatments in cancer therapy. Her innovative spirit and collaborative efforts are making a meaningful impact in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…